These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22533740)

  • 1. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.
    Ailawadhi S; Aldoss IT; Yang D; Razavi P; Cozen W; Sher T; Chanan-Khan A
    Br J Haematol; 2012 Jul; 158(1):91-8. PubMed ID: 22533740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.
    Ailawadhi S; Kardosh A; Yang D; Cozen W; Patel G; Alamgir MA; Chanan-Khan AA
    Oncology; 2014; 86(5-6):253-62. PubMed ID: 24902770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
    Ailawadhi S; Azzouqa AG; Hodge D; Cochuyt J; Jani P; Ahmed S; Sher T; Roy V; Ailawadhi M; Alegria VR; Manochakian R; Vishnu P; Grover A; Abdulazeez MF; Paulus A; Chanan-Khan A
    Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):619-623. PubMed ID: 31377212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
    Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
    Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.
    Ailawadhi S; Advani P; Yang D; Ghosh R; Swaika A; Roy V; Foran J; Colon-Otero G; Chanan-Khan A
    Cancer; 2016 Feb; 122(4):618-25. PubMed ID: 26565660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.
    Ailawadhi S; Frank RD; Advani P; Swaika A; Temkit M; Menghani R; Sharma M; Meghji Z; Paulus S; Khera N; Hashmi SK; Paulus A; Kakar TS; Hodge DO; Colibaseanu DT; Vizzini MR; Roy V; Colon-Otero G; Chanan-Khan AA
    Cancer Med; 2017 Dec; 6(12):2876-2885. PubMed ID: 29105343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.
    Costa LJ; Brill IK; Brown EE
    Cancer; 2016 Oct; 122(20):3183-3190. PubMed ID: 27548407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis.
    Ailawadhi S; Parikh K; Abouzaid S; Zhou Z; Tang W; Clancy Z; Cheung C; Zhou ZY; Xie J
    Blood Adv; 2019 Oct; 3(20):2986-2994. PubMed ID: 31648322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review.
    Crozier JA; Sher T; Yang D; Swaika A; Foran J; Ghosh R; Tun H; Colon-Otero G; Kelly K; Chanan-Khan A; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):578-85. PubMed ID: 26198444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
    Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
    Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.
    Pulte D; Redaniel MT; Brenner H; Jansen L; Jeffreys M
    Leuk Lymphoma; 2014 May; 55(5):1083-9. PubMed ID: 23879201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in survival for patients with clinically localized prostate cancer adjusted for treatment effects.
    Tyson MD; Castle EP
    Mayo Clin Proc; 2014 Mar; 89(3):300-7. PubMed ID: 24582189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in the outcomes of superficial vein treatments for chronic venous insufficiency.
    Pappas PJ; Pappas SF; Nguyen KQ; Lakhanpal S
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):789-798.e3. PubMed ID: 32205126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.
    Castañeda-Avila MA; Ortiz-Ortiz KJ; Torres-Cintrón CR; Birmann BM; Epstein MM
    Int J Cancer; 2020 Jan; 146(1):35-43. PubMed ID: 30802944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Disparities, Outcomes, and Surgical Utilization among Hispanics with Esophageal Cancer: A Surveillance, Epidemiology, and End Results Program Database Analysis.
    Gupta DR; Liu Y; Jiang R; Walid S; Higgins K; Landry J; McDonald M; Willingham FF; El-Rayes BF; Saba NF
    Oncology; 2019; 97(1):49-58. PubMed ID: 31108497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis.
    Wei JX; Shastri A; Sica RA; Mantzaris I; Kornblum N; Shah U; Janakiram M; Gritsman K; Verma A; Goldfinger M; Cooper D; Shah N
    Haematologica; 2024 May; 109(5):1480-1486. PubMed ID: 37881838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
    Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients.
    Kaya H; Peressini B; Jawed I; Martincic D; Elaimy AL; Lamoreaux WT; Fairbanks RK; Weeks KA; Lee CM
    Int J Hematol; 2012 Jan; 95(1):64-70. PubMed ID: 22160833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data.
    Kaur G; Mejia Saldarriaga M; Shah N; Catamero DD; Yue L; Ashai N; Goradia N; Heisler J; Xiao Z; Ghalib N; Aaron T; Cole D; Foreman R; Mantzaris I; Derman O; Bachier L; Sica RA; Kornblum N; Braunschweig I; Shastri A; Goel S; Verma A; Janakiram M
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e384-e397. PubMed ID: 33339770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.
    Barnholtz-Sloan JS; Maldonado JL; Williams VL; Curry WT; Rodkey EA; Barker FG; Sloan AE
    J Neurooncol; 2007 Nov; 85(2):171-80. PubMed ID: 17530174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.